Kopran
Ticker > Company >

Kopran share price

Kopran Ltd.

NSE: KOPRAN BSE: 524280 SECTOR: Pharmaceuticals & Drugs  74.65 K   149   29

176.00
-1.70 (-0.96%)
BSE: 17 Sep 04:01 PM

Price Summary

Today's High

₹ 178.7

Today's Low

₹ 176

52 Week High

₹ 357.35

52 Week Low

₹ 154.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 849.83 Cr.

Enterprise Value

₹ 874.12 Cr.

No. of Shares

4.83 Cr.

P/E

32.53

P/B

1.96

Face Value

₹ 10

Div. Yield

1.7 %

Book Value (TTM)

₹  89.75

CASH

₹ 21.02 Cr.

DEBT

₹ 45.31 Cr.

Promoter Holding

44.42 %

EPS (TTM)

₹  5.41

Sales Growth

-19.69%

ROE

6.35 %

ROCE

8.63%

Profit Growth

-22.46 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-19.69%
3 Year9.84%
5 Year8.61%

Profit Growth

1 Year-22.46%
3 Year31.75%
5 Year19.07%

ROE%

1 Year6.35%
3 Year7.65%
5 Year7.31%

ROCE %

1 Year8.63%
3 Year9.81%
5 Year9.73%

Debt/Equity

0.1054

Price to Cash Flow

36.48

Interest Cover Ratio

10.5035

CFO/PAT (5 Yr. Avg.)

0.672815637166717

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 44.42 0.00
Mar 2025 44.42 0.00
Dec 2024 44.46 0.00
Sep 2024 44.49 0.00
Jun 2024 44.49 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.7465168382377% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 10.5035.
  • The company has an efficient Cash Conversion Cycle of 55.4063 days.
  • Company has a healthy liquidity position with current ratio of 2.0232.

 Limitations

  • The company has shown a poor revenue growth of 9.8370566324494% for the Past 3 years.
  • Company has a poor ROE of 7.65373333333333% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 49.61 73.53 71.94 75.94 51.34
Total Expenditure 44.33 63.84 60.54 63.65 46.26
Operating Profit 5.28 9.69 11.4 12.29 5.07
Other Income 2.12 1.12 0.75 1.92 1.8
Interest 0.69 0.83 0.99 1.26 1.04
Depreciation 1.2 1.23 1.33 1.24 1.22
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.51 8.75 9.83 11.71 4.61
Tax 1.27 2.14 2.42 3.11 1.09
Profit After Tax 4.25 6.6 7.41 8.6 3.52
Adjusted EPS (Rs) 0.88 1.37 1.54 1.78 0.73

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 222.83 204.52 273.09 337.46 271.01
Total Expenditure 192.68 189.26 245.18 300.59 232.36
Operating Profit 30.15 15.26 27.91 36.87 38.65
Other Income 10.46 8.18 16.09 16.77 5.91
Interest 3.81 2.95 2.67 4.5 3.77
Depreciation 4.1 4.32 4.41 4.62 5
Exceptional Items 0 0 0 0 0
Profit Before Tax 32.71 16.16 36.92 44.52 35.79
Tax 9.23 4.42 5.66 9.88 8.94
Net Profit 23.47 11.74 31.25 34.64 26.86
Adjusted EPS (Rs.) 5.43 2.44 6.48 7.18 5.56

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 43.25 48.21 48.21 48.21 48.29
Total Reserves 203.6 330.51 347.38 368.66 383.15
Borrowings 2.36 2.08 2.3 2.23 3.56
Other N/C liabilities 6.17 7.07 7.18 7.24 8.16
Current liabilities 68.57 76.25 100.88 84.54 103.33
Total Liabilities 323.95 464.12 505.95 510.88 546.48
Assets
Net Block 47.44 46.22 47.35 52.02 61.45
Capital WIP 0 0 0 0 2.1
Intangible WIP 2.82 3.1 3.53 4.7 5.34
Investments 158.79 259.43 260.07 261.27 263.07
Loans & Advances 3.74 3.92 4.1 4.71 5.2
Other N/C Assets 0.04 0.14 0.49 0.47 0.28
Current Assets 111.12 151.31 190.41 187.7 209.05
Total Assets 323.95 464.12 505.95 510.88 546.48
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 32.71 16.16 36.92 44.52 35.79
Adjustment 7.38 4.17 -9.04 2.69 6.59
Changes in Assets & Liabilities 14.1 -54.53 -4.68 -2.41 -8.99
Tax Paid -5.41 -3.61 -6.32 -9.83 -10.1
Operating Cash Flow 48.77 -37.8 16.87 34.96 23.3
Investing Cash Flow -8.51 -100.26 10.05 -6.27 -15.41
Financing Cash Flow -40.14 137.99 -26.13 -24.08 5.64
Net Cash Flow 0.12 -0.07 0.79 4.61 13.53

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 44.49 44.49 44.46 44.42 44.42
hridai susheel somani 0.24 0.24 0.24 0.24 0.24
jaya somani 0.54 0.54 0.54 0.54 0.54
mr adarsh somani 0.38 0.38 0.38 0.38 0.38
mridula somani 1.64 1.64 5.29 1.63 1.63
nupur somani 0.56 0.56 0.56 0.56 0.56
oricon enterprises limite... - - - 12.88 12.88
panorama finvest pvt ltd 7.88 7.88 7.88 7.87 7.87
parijat shipping and fina... 0.80 0.80 1.89 1.89 1.89
sarvamangal mercantile co... - - - 6.01 6.01
somani kumkum 0.07 0.07 0.07 0.07 0.07
suhrid somani 0.19 0.19 0.19 0.19 0.19
surendra somani 1.24 1.24 1.24 4.50 4.50
susheel somani 1.81 1.81 0.56 0.56 0.56
united shippers ltd 4.56 4.56 4.56 4.56 4.56
vandana somani 0.72 0.72 0.72 1.43 1.43
varun somani 0.57 0.57 0.72 1.11 1.11
kopran lifestyle limited 0.01 0.01 0.01 0.01 -
g.claridge & company limi... 0.71 0.71 0.71 - -
oricon enterprises ltd 12.90 12.90 12.89 - -
sarvamangal mercantile co... 6.02 6.02 6.02 - -
rajendra somani 3.66 3.66 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 55.51 55.51 55.54 55.58 55.58
laxminarayan vyapaar p lt... 1.95 1.56 1.56 1.56 1.56
madhuri madhusudan kela .... - - - 1.46 1.46
viraj russell mehta 1.85 1.85 1.85 1.85 1.02
madhuri madhusudan kela 1.04 1.04 1.04 - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q3FY25
Concall Q3FY25
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY21
Presentation Q2FY21
Presentation Q1FY25

Company News

Kopran informs about disclosure 9 Sep, 4:30 PM Kopran informs about record date 11 Aug, 5:35 PM Kopran - Quaterly Results 29 Jul, 2:19 PM Kopran - Quaterly Results 29 Jul, 2:19 PM Kopran - Quaterly Results 29 Jul, 2:19 PM Kopran informs about newspaper advertisement 16 May, 5:37 PM Kopran - Quaterly Results 15 May, 3:18 PM Kopran - Quaterly Results 15 May, 3:18 PM Kopran - Quaterly Results 15 May, 3:18 PM USFDA concludes surveillance inspection at API unit of Kopran’s arm 29 Apr, 3:10 PM Kopran informs about compliance certificate 8 Apr, 5:27 PM Kopran informs about recording of investors conference 27 Mar, 5:07 PM Kopran informs about trading window closure 27 Mar, 2:37 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran - Quaterly Results 11 Feb, 3:28 PM Kopran informs about certificate 8 Jan, 5:13 PM Kopran informs about compliances-certificate 10 Oct, 4:15 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran - Quaterly Results 8 Aug, 12:35 PM Kopran’s arm gets environmental clearance to manufacture synthetic organic chemicals 31 Jul, 2:56 PM Kopran informs about issuance of duplicated share certificate 26 Jul, 5:16 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran - Quaterly Results 16 May, 1:28 PM Kopran informs about details of loss of certificate 19 Mar, 1:01 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran - Quaterly Results 7 Feb, 1:42 PM Kopran informs about loss of share certificate 17 Jan, 5:19 PM Kopran informs about issue of duplicate share certificate 21 Nov, 3:04 PM Kopran informs about loss of share certificate 17 Nov, 5:15 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran - Quaterly Results 7 Nov, 1:34 PM Kopran informs about board meeting 26 Oct, 2:40 PM Kopran informs about issuance of duplicate share certificate 19 Oct, 2:35 PM Kopran informs about details of loss of certificate 6 Oct, 4:23 PM Kopran informs about closure of trading window 26 Sep, 4:48 PM Kopran informs about loss of share certificate 22 Sep, 5:22 PM Kopran informs about details of loss of certificate 11 Sep, 4:39 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 10 Aug, 12:51 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran - Quaterly Results 25 May, 3:15 PM Kopran informs about PCS certificate 21 Apr, 4:37 PM Kopran informs about details of loss of certificate 23 Feb, 4:50 PM

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Kopran. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Kopran has a PE ratio of 32.6137980742575 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Kopran has ROA of 5.0799% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Kopran has a Current ratio of 2.0232.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Kopran has a ROE of 6.3516%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Kopran has a Debt to Equity ratio of 0.1054 which means that the company has low proportion of debt in its capital.

  • Sales growth: Kopran has reported revenue growth of -19.6903% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Kopran for the current financial year is 14.2618985681314%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Kopran is Rs 3 and the yield is 1.6968%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Kopran is Rs 5.4109. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Kopran in Ticker for free. Also, one can get the intrinsic value of Kopran by using Valuation Calculators, which are available with a Finology ONE subscription. 

Kopran FAQs

Q1. What is Kopran share price today?
Ans: The current share price of Kopran is Rs 176.47.

Q2. What is the market capitalisation of Kopran?
Ans: Kopran has a market capitalisation of Rs 852.096071435 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Kopran?
Ans: The PE ratio of Kopran is 32.6137980742575 and the P/B ratio of Kopran is 1.96634910022842, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Kopran share?
Ans: The 52-week high share price of Kopran is Rs 357, and the 52-week low share price of Kopran is Rs 154.06.

Q5. Does Kopran pay dividends?
Ans: Currently, Kopran pays dividends. Dividend yield of Kopran is around 1.6968%.

Q6. What are the face value and book value of Kopran shares?
Ans: The face value of Kopran shares is Rs 10, while the book value per share of Kopran is around Rs 89.745. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Kopran?
Ans: Kopran has a total debt of Rs 45.311 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Kopran?
Ans: The ROE of Kopran is 6.3516% and ROCE of Kopran is 8.6347%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Kopran a good buy for the long term?
Ans: The Kopran long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Kopran undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Kopran appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Kopran’s financials?
Ans: You can review Kopran’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Kopran

Kopran Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Kopran Limited is a leading pharmaceutical company in India, dedicated to manufacturing and marketing a wide range of healthcare products. With a rich history of over three decades, Kopran has emerged as a trusted brand in the pharmaceutical industry. The company focuses on developing and producing high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products.

Share Price - Kopran Limited

Kopran Limited's share price reflects the market valuation of the company's stock. The share price is influenced by various factors such as the company's financial performance, industry trends, and market sentiment. As a long-term stock investor, it is crucial to analyze the share price movement to make informed investment decisions. Our pre-built screening tools allow you to track and analyze the share price of Kopran Limited over time, enabling you to identify potential investment opportunities.

Balance Sheet - Kopran Limited

The balance sheet provides a snapshot of a company's financial position, representing its assets, liabilities, and shareholders' equity. Kopran Limited's balance sheet showcases the company's financial stability and growth prospects. Utilizing our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can calculate the fair value of Kopran Limited's stock based on the balance sheet data. These tools enable investors to assess the company's intrinsic value and make informed investment decisions.

Annual Report - Kopran Limited

The annual report of Kopran Limited provides comprehensive insights into the company's performance, achievements, and future prospects. Our website offers downloadable annual reports for Kopran Limited, allowing investors to analyze the company's financials, management discussions, and outlook. By studying the annual report, investors can gain a deeper understanding of Kopran Limited's business strategies and make informed investment decisions.

Dividend - Kopran Limited

Kopran Limited has a history of rewarding its shareholders through dividends. Dividends are a portion of the company's profits distributed among its shareholders. Monitoring the dividend payout and dividend yield of Kopran Limited can be crucial for long-term investors seeking regular income from their investments. By utilizing our pre-built screening tools, investors can easily track the dividend history and dividend yield of Kopran Limited, helping them make investment decisions aligned with their income goals.

Quarterly Result - Kopran Limited

The quarterly results of Kopran Limited provide updated information on the company's financial performance during a specific three-month period. Investors can evaluate the company's revenue growth, profitability, and other key financial metrics by analyzing the quarterly results. Our website offers quarterly result updates for Kopran Limited, allowing investors to stay informed and assess the company's ongoing performance.

Stock Price - Kopran Limited

The stock price of Kopran Limited represents the market value of the company's shares. Tracking the stock price movement is essential for investors to gauge market sentiment and assess the performance of their investment. Our website provides a price chart that displays the historical stock price movement of Kopran Limited, enabling investors to identify trends and patterns, aiding in their analysis and decision-making process.

News - Kopran Limited

Staying updated with the latest news and developments related to Kopran Limited is crucial for investors. Our website provides a dedicated news section for Kopran Limited, where investors can access relevant news articles, press releases, and corporate announcements. By keeping abreast of the news, investors can stay informed about the company's activities, industry trends, and market dynamics, supporting their investment analysis.

Concall Transcripts - Kopran Limited

Concall transcripts provide valuable insights into the discussions and Q&A sessions that take place during the company's earnings conference calls. Our website offers downloadable concall transcripts for Kopran Limited, allowing investors to read and analyze the discussions between the company's management and analysts. By studying these transcripts, investors can gain a deeper understanding of the company's performance, growth strategies, and future outlook.

Investor Presentations - Kopran Limited

Investor presentations are a valuable resource for understanding a company's business model, growth plans, and financial performance. Kopran Limited provides investor presentations that offer a comprehensive overview of the company's operations, market position, and future prospects. By accessing these downloadable presentations on our website, investors can delve into the details and make informed investment decisions.

Promoters - Kopran Limited

The promoters of Kopran Limited play a crucial role in shaping the company's vision, strategic direction, and overall growth. Our website provides information about the key promoters of Kopran Limited, including their background, experience, and contribution to the company's success. By understanding the promoters' involvement and commitment to the company, investors can assess the company's governance and long-term stability.

Shareholders - Kopran Limited

The shareholders of Kopran Limited are an essential part of the company's ownership structure. Our website offers insights into the major shareholders of Kopran Limited, including institutional investors, mutual funds, and individual investors. By studying the shareholder composition, investors can gain insights into the market perception of the company and identify influential stakeholders who may impact the company's strategic decisions.

In conclusion, the content above provides a comprehensive analysis of Kopran Limited's stock, catering to long-term stock investors seeking detailed information about the company. By utilizing our pre-built screening tools and premium features, investors can access valuable resources such as annual reports, concall transcripts, investor presentations, and more, enabling them to make well-informed investment decisions. 

Kopran's Steady Growth in Reserves

Kopran has demonstrated a consistent increase in total reserves over the last five years. From March 2020 to March 2024, total reserves grew from Rs 186.42 Cr. to a substantial Rs 368.66 Cr. This growth signifies a robust reserve accumulation strategy, underpinning Kopran's financial resilience.

Subdued Borrowings on Kopran's Balance Sheet

Kopran has managed to maintain a low level of borrowings through the years, with a minor uptick from Rs 2.08 Cr. in March 2022 to Rs 2.30 Cr. in March 2023, before slightly decreasing to Rs 2.23 Cr. in March 2024. This indicates a conservative approach to leverage and a focus on maintaining a strong balance sheet.

Expansion in Kopran's Asset Base

The company's total assets have seen a consistent rise, from Rs 325.85 Cr. in March 2020 to Rs 510.88 Cr. by March 2024. Notably, investment assets increased significantly from Rs 158.14 Cr. to Rs 261.27 Cr., showing Kopran's growing asset pool and possible revenue-generating investments.

Kopran's Current Assets and Liabilities

Current assets moved upward, indicating a healthy liquidity position from Rs 114.23 Cr. in March 2020 to Rs 187.70 Cr. in March 2024. However, there was also an increase in current liabilities, particularly between March 2022 and March 2023, before a slight reduction in 2024.

This data presents an analysis for the standalone balance sheet of Kopran. In addition to providing insights for stock screening, understanding a corporation's financial health is a pivotal aspect of evaluating its position relative to market indices such as the NSE or BSE, sector performance, or potential IPO valuations.

Read More
X